Related Experiment Video
Updated: Jun 17, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Dyslipidemia in the elderly: should it be treated?
Madhan Shanmugasundaram1, Steven J Rough, Joseph S Alpert
1Department of Internal Medicine, University of Arizona College of Medicine, Tucson, Arizona 85724, USA. smadhan13@gmail.com
Clinical Cardiology
|January 12, 2010
Summary
Older adults face rising cardiovascular disease risks due to dyslipidemia. Despite proven benefits, lipid-lowering therapies are underutilized in this population, highlighting a critical gap in care.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Pharmacology
Background:
- Cardiovascular disease (CVD) is a growing concern in the elderly population, with dyslipidemia as a major risk factor.
- Dyslipidemia contributes to over half of all coronary artery disease cases globally.
- Underdiagnosis and undertreatment of dyslipidemia in older adults persist due to evidence gaps and safety concerns.
Purpose of the Study:
- To examine the persistent controversy surrounding the benefits of lipid-lowering therapy in older adults.
- To identify reasons for the underutilization of effective CVD treatments in this demographic.
Main Methods:
- Review of epidemiologic studies on dyslipidemia prevalence and treatment in older adults.
- Analysis of factors contributing to treatment hesitancy, including evidence of efficacy, adverse events, and cost-effectiveness.
Main Results:
- Dyslipidemia is prevalent and a significant risk factor for CVD in the elderly.
- Despite proven efficacy, lipid-lowering therapies are underutilized in older patients.
- Concerns about adverse events and cost-effectiveness contribute to undertreatment.
Conclusions:
- Lipid-lowering therapies are effective in reducing cardiovascular morbidity and mortality in older adults.
- There is a critical need to address the underutilization of these proven therapies in the elderly population.
- Further research and clinical guidelines may be needed to clarify treatment benefits and address concerns.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...